Stallion India Fluorochemicals Limited has announced the allotment of an industrial plot from Rajasthan State Industrial Development & Investment Corporation Limited (RIICO), marking a significant step in the company's expansion strategy. The disclosure was made in compliance with SEBI regulations on January 19, 2026.

Plot Allotment Details

The company received an allotment letter dated November 4, 2025, from RIICO for the allocation of industrial land in Rajasthan. The plot details are as follows:

Strategic Expansion Initiative

The allotment is strategically positioned to support the company's long-term expansion plans and future growth objectives. The new plot will complement the operational requirements of Stallion India's existing R-32 Manufacturing Plant, which is situated at the adjacent Plot No. SP3-10 in RIICO Industrial Area, Ukhaliya, Tehsil – Hurda, District – Bhilwara, Rajasthan.

Regulatory Compliance

The company made this disclosure pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was signed by Govind Rao, Company Secretary & Compliance Officer, ensuring adherence to applicable regulatory provisions.

Manufacturing Operations Context

The allotment supports the company's fluorochemicals manufacturing operations, particularly its R-32 production facility. The proximity of the new plot to the existing manufacturing plant is expected to provide operational synergies and support the company's expansion in the fluorochemicals sector.

Stallion India Fluorochemicals Limited has announced that its Board of Directors will convene on January 21, 2026, to consider fund raising proposals. The meeting, scheduled for Wednesday, will deliberate on various financing options as the company explores capital expansion opportunities.

Fund Raising Proposal Details

The board meeting will focus on fund raising through multiple financial instruments and methods. The company has outlined several potential approaches for capital mobilization:

The proposal encompasses raising funds through equity shares or any other securities via appropriate modes, including rights issue, as permitted under applicable law. The final decision on the funding method will be determined by the Board during the meeting, subject to obtaining necessary regulatory and statutory approvals.

Trading Window Restrictions

In accordance with insider trading prevention measures, Stallion India Fluorochemicals has implemented trading window restrictions. The company has closed the trading window for its securities effective from the time of this intimation.

The trading window closure will remain in effect until 48 hours after the publication of the board meeting outcome. This measure aligns with the company's Code of Conduct for Prevention of Insider Trading, adopted in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Regulatory Compliance

The board meeting intimation has been issued pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both NSE and BSE about the scheduled meeting, ensuring full compliance with listing regulations.

Company Secretary and Compliance Officer Govind Rao has signed the intimation notice, confirming the company's adherence to regulatory requirements. The formal communication was dispatched to stock exchanges on January 18, 2026, providing adequate notice period as mandated by listing regulations.